Utility of autologous fibrin glue and polyglycolic acid sheet for preventing delayed bleeding associated with antithrombotic therapy after gastric ESD

Background and study aims Delayed bleeding is one of the most serious adverse events of gastric endoscopic submucosal dissection (ESD), especially in patients taking antithrombotic therapy. This study aimed to evaluate the utility and safety of a shielding method with autologous fibrin glue and poly...

Full description

Bibliographic Details
Main Authors: Daisuke Kikuchi, Toshiro Iizuka, Shigeyoshi Makino, Junnosuke Hayasaka, Hiroyuki Odagiri, Yorinari Ochiai, Yugo Suzuki, Kosuke Nomura, Yu Ohkura, Yosuke Okamoto, Masami Tanaka, Akira Matsui, Toshifumi Mitani, Shu Hoteya
Format: Article
Language:English
Published: Georg Thieme Verlag KG 2019-11-01
Series:Endoscopy International Open
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/a-1007-1694
_version_ 1811323440430317568
author Daisuke Kikuchi
Toshiro Iizuka
Shigeyoshi Makino
Junnosuke Hayasaka
Hiroyuki Odagiri
Yorinari Ochiai
Yugo Suzuki
Kosuke Nomura
Yu Ohkura
Yosuke Okamoto
Masami Tanaka
Akira Matsui
Toshifumi Mitani
Shu Hoteya
author_facet Daisuke Kikuchi
Toshiro Iizuka
Shigeyoshi Makino
Junnosuke Hayasaka
Hiroyuki Odagiri
Yorinari Ochiai
Yugo Suzuki
Kosuke Nomura
Yu Ohkura
Yosuke Okamoto
Masami Tanaka
Akira Matsui
Toshifumi Mitani
Shu Hoteya
author_sort Daisuke Kikuchi
collection DOAJ
description Background and study aims Delayed bleeding is one of the most serious adverse events of gastric endoscopic submucosal dissection (ESD), especially in patients taking antithrombotic therapy. This study aimed to evaluate the utility and safety of a shielding method with autologous fibrin glue and polyglycolic acid (PGA) sheets for patients undergoing gastric ESD who are receiving antithrombotic therapy. Patients and methods One hundred twenty-three patients who were treated with gastric ESD while receiving antithrombotic therapy between December 2014 and September 2017 were enrolled in this study. Patients who received the shielding method were classified into the shielding group. Others were classified into the conventional group. Various clinico-pathological factors were retrospectively compared between the two groups. Results The shielding group consisted of 38 patients, and the conventional group consisted of the remaining 85 patients. In the shielding group, the rate of continuation of antithrombotic therapy was significantly higher (68.4 % vs 41.2 %). Incidence of delayed bleeding was lower in the shielding group (2.6 %, 1/38) than in the conventional group (14.1 %, 12/85). In the propensity score-adjusted logistic regression analysis, the delayed bleeding rate in the shielding group tended to be lower than in the conventional group (P = 0.070). Allogeneic transfusion was performed in eight patients (8/85, 9.4 %) in the conventional group and none in the shielding group (P = 0.047). No adverse event associated with endoscopic shielding were observed in the shielding group. Conclusions This study suggests that a shielding method with autologous fibrin glue and PGA sheet effectively prevents delayed bleeding after gastric ESD in patients receiving antithrombotic therapy.
first_indexed 2024-04-13T13:55:12Z
format Article
id doaj.art-21b327de977a4c07bc9902781442e35e
institution Directory Open Access Journal
issn 2364-3722
2196-9736
language English
last_indexed 2024-04-13T13:55:12Z
publishDate 2019-11-01
publisher Georg Thieme Verlag KG
record_format Article
series Endoscopy International Open
spelling doaj.art-21b327de977a4c07bc9902781442e35e2022-12-22T02:44:14ZengGeorg Thieme Verlag KGEndoscopy International Open2364-37222196-97362019-11-010711E1542E154810.1055/a-1007-1694Utility of autologous fibrin glue and polyglycolic acid sheet for preventing delayed bleeding associated with antithrombotic therapy after gastric ESDDaisuke Kikuchi0Toshiro Iizuka1Shigeyoshi Makino2Junnosuke Hayasaka3Hiroyuki Odagiri4Yorinari Ochiai5Yugo Suzuki6Kosuke Nomura7Yu Ohkura8Yosuke Okamoto9Masami Tanaka10Akira Matsui11Toshifumi Mitani12Shu Hoteya13Department of Gastroenterology, Toranomon Hospital, Tokyo, JapanDepartment of Gastroenterology, Toranomon Hospital, Tokyo, JapanDepartment of Transfusion medicine, Toranomon Hospital, Tokyo, JapanDepartment of Gastroenterology, Toranomon Hospital, Tokyo, JapanDepartment of Gastroenterology, Toranomon Hospital, Tokyo, JapanDepartment of Gastroenterology, Toranomon Hospital, Tokyo, JapanDepartment of Gastroenterology, Toranomon Hospital, Tokyo, JapanDepartment of Gastroenterology, Toranomon Hospital, Tokyo, JapanDepartment of Surgery, Toranomon Hospital, Tokyo, JapanDepartment of Gastroenterology, Toranomon Hospital, Tokyo, JapanDepartment of Gastroenterology, Toranomon Hospital, Tokyo, JapanDepartment of Gastroenterology, Toranomon Hospital, Tokyo, JapanDepartment of Gastroenterology, Toranomon Hospital, Tokyo, JapanDepartment of Gastroenterology, Toranomon Hospital, Tokyo, JapanBackground and study aims Delayed bleeding is one of the most serious adverse events of gastric endoscopic submucosal dissection (ESD), especially in patients taking antithrombotic therapy. This study aimed to evaluate the utility and safety of a shielding method with autologous fibrin glue and polyglycolic acid (PGA) sheets for patients undergoing gastric ESD who are receiving antithrombotic therapy. Patients and methods One hundred twenty-three patients who were treated with gastric ESD while receiving antithrombotic therapy between December 2014 and September 2017 were enrolled in this study. Patients who received the shielding method were classified into the shielding group. Others were classified into the conventional group. Various clinico-pathological factors were retrospectively compared between the two groups. Results The shielding group consisted of 38 patients, and the conventional group consisted of the remaining 85 patients. In the shielding group, the rate of continuation of antithrombotic therapy was significantly higher (68.4 % vs 41.2 %). Incidence of delayed bleeding was lower in the shielding group (2.6 %, 1/38) than in the conventional group (14.1 %, 12/85). In the propensity score-adjusted logistic regression analysis, the delayed bleeding rate in the shielding group tended to be lower than in the conventional group (P = 0.070). Allogeneic transfusion was performed in eight patients (8/85, 9.4 %) in the conventional group and none in the shielding group (P = 0.047). No adverse event associated with endoscopic shielding were observed in the shielding group. Conclusions This study suggests that a shielding method with autologous fibrin glue and PGA sheet effectively prevents delayed bleeding after gastric ESD in patients receiving antithrombotic therapy.http://www.thieme-connect.de/DOI/DOI?10.1055/a-1007-1694
spellingShingle Daisuke Kikuchi
Toshiro Iizuka
Shigeyoshi Makino
Junnosuke Hayasaka
Hiroyuki Odagiri
Yorinari Ochiai
Yugo Suzuki
Kosuke Nomura
Yu Ohkura
Yosuke Okamoto
Masami Tanaka
Akira Matsui
Toshifumi Mitani
Shu Hoteya
Utility of autologous fibrin glue and polyglycolic acid sheet for preventing delayed bleeding associated with antithrombotic therapy after gastric ESD
Endoscopy International Open
title Utility of autologous fibrin glue and polyglycolic acid sheet for preventing delayed bleeding associated with antithrombotic therapy after gastric ESD
title_full Utility of autologous fibrin glue and polyglycolic acid sheet for preventing delayed bleeding associated with antithrombotic therapy after gastric ESD
title_fullStr Utility of autologous fibrin glue and polyglycolic acid sheet for preventing delayed bleeding associated with antithrombotic therapy after gastric ESD
title_full_unstemmed Utility of autologous fibrin glue and polyglycolic acid sheet for preventing delayed bleeding associated with antithrombotic therapy after gastric ESD
title_short Utility of autologous fibrin glue and polyglycolic acid sheet for preventing delayed bleeding associated with antithrombotic therapy after gastric ESD
title_sort utility of autologous fibrin glue and polyglycolic acid sheet for preventing delayed bleeding associated with antithrombotic therapy after gastric esd
url http://www.thieme-connect.de/DOI/DOI?10.1055/a-1007-1694
work_keys_str_mv AT daisukekikuchi utilityofautologousfibringlueandpolyglycolicacidsheetforpreventingdelayedbleedingassociatedwithantithrombotictherapyaftergastricesd
AT toshiroiizuka utilityofautologousfibringlueandpolyglycolicacidsheetforpreventingdelayedbleedingassociatedwithantithrombotictherapyaftergastricesd
AT shigeyoshimakino utilityofautologousfibringlueandpolyglycolicacidsheetforpreventingdelayedbleedingassociatedwithantithrombotictherapyaftergastricesd
AT junnosukehayasaka utilityofautologousfibringlueandpolyglycolicacidsheetforpreventingdelayedbleedingassociatedwithantithrombotictherapyaftergastricesd
AT hiroyukiodagiri utilityofautologousfibringlueandpolyglycolicacidsheetforpreventingdelayedbleedingassociatedwithantithrombotictherapyaftergastricesd
AT yorinariochiai utilityofautologousfibringlueandpolyglycolicacidsheetforpreventingdelayedbleedingassociatedwithantithrombotictherapyaftergastricesd
AT yugosuzuki utilityofautologousfibringlueandpolyglycolicacidsheetforpreventingdelayedbleedingassociatedwithantithrombotictherapyaftergastricesd
AT kosukenomura utilityofautologousfibringlueandpolyglycolicacidsheetforpreventingdelayedbleedingassociatedwithantithrombotictherapyaftergastricesd
AT yuohkura utilityofautologousfibringlueandpolyglycolicacidsheetforpreventingdelayedbleedingassociatedwithantithrombotictherapyaftergastricesd
AT yosukeokamoto utilityofautologousfibringlueandpolyglycolicacidsheetforpreventingdelayedbleedingassociatedwithantithrombotictherapyaftergastricesd
AT masamitanaka utilityofautologousfibringlueandpolyglycolicacidsheetforpreventingdelayedbleedingassociatedwithantithrombotictherapyaftergastricesd
AT akiramatsui utilityofautologousfibringlueandpolyglycolicacidsheetforpreventingdelayedbleedingassociatedwithantithrombotictherapyaftergastricesd
AT toshifumimitani utilityofautologousfibringlueandpolyglycolicacidsheetforpreventingdelayedbleedingassociatedwithantithrombotictherapyaftergastricesd
AT shuhoteya utilityofautologousfibringlueandpolyglycolicacidsheetforpreventingdelayedbleedingassociatedwithantithrombotictherapyaftergastricesd